Prothrombin time (PT) and CEA as prognostic predictive biomarkers for postoperative recurrence after curative resection in patients with stage I–III colorectal cancer: a retrospective cohort study-Reference-Cited by-同舟云学术

Prothrombin time (PT) and CEA as prognostic predictive biomarkers for postoperative recurrence after curative resection in patients with stage I–III colorectal cancer: a retrospective cohort study

Published:2022-03-24 Issue:3 Volume:74 Page:999-1009
ISSN:2038-131X
Container-title:Updates in Surgery
language:en
Short-container-title:Updates Surg

Author:

Ma Lulu,Li Wenya,Liu Ningquan,Ding Zhijie,Cai Jianchun,Zhang Yiyao^ORCID

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

https://link.springer.com/content/pdf/10.1007/s13304-022-01268-8.pdf

Reference30 articles.

1. Benson AB 3rd, Venook AP, Cederquist L, Chan E, Chen YJ, Cooper HS, Deming D, Engstrom PF, Enzinger PC, Fichera A, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wu CS, Gregory KM, Freedman-Cass D (2017) Colon Cancer, Version 12017, NCCN Clinical Practice Guidelines in Oncology. J Natl Comprehensive Cancer Netw 15(3):370–398. https://doi.org/10.6004/jnccn.2017.0036

2. Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, Nordlinger B, van de Velde CJ, Balmana J, Regula J, Nagtegaal ID, Beets-Tan RG, Arnold D, Ciardiello F, Hoff P, Kerr D, Kohne CH, Labianca R, Price T, Scheithauer W, Sobrero A, Tabernero J, Aderka D, Barroso S, Bodoky G, Douillard JY, El Ghazaly H, Gallardo J, Garin A, Glynne-Jones R, Jordan K, Meshcheryakov A, Papamichail D, Pfeiffer P, Souglakos I, Turhal S, Cervantes A (2012) ESMO Consensus Guidelines for management of patients with colon and rectal cancer: a personalized approach to clinical decision making. Ann Oncol 23(10):2479–2516. https://doi.org/10.1093/annonc/mds236

3. Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–1474. https://doi.org/10.1245/s10434-010-0985-4

4. Argiles G, Tabernero J, Labianca R, Hochhauser D, Salazar R, Iveson T, Laurent-Puig P, Quirke P, Yoshino T, Taieb J, Martinelli E, Arnold D (2020) Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 31(10):1291–1305. https://doi.org/10.1016/j.annonc.2020.06.022

5. Boland CR, Goel A (2016) Prognostic subgroups among patients with Stage II colon cancer. N Engl J Med 374(3):277–278. https://doi.org/10.1056/NEJMe1514353

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical value of a nomogram constructed from CEA, CA199, PT, FIB, tumor differentiation and TNM stage in colorectal cancer;Cancer Biomarkers;2023-12-15

2. Establishment and validation of a nomogram based on coagulation parameters to predict the prognosis of pancreatic cancer;BMC Cancer;2023-06-15

3. Association between PT, PT-INR, and in-hospital mortality in critically ill patients with tumors: A retrospective cohort study;Frontiers in Public Health;2023-03-21

4. Perineural invasion-associated biomarkers for tumor development;Biomedicine & Pharmacotherapy;2022-11